RB1 and lung carcinoma: Therefore, we suspect that both p21WAF1/CIP1-mediated inhibition as well as the down-regulation of CDK 4/6 and pRB may majorly contribute to the decrease in PD-L1 expression in lung cancer cells following SAHA treatment.